Last Price
54.16
Today's Change
+0.23 (0.42%)
Day's Change
53.35 - 54.48
Trading Volume
162,292
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Nikhil Lalwani Mr. Nikhil Lalwani
Full Time Employees: 642 642
IPO Date: 2000-05-05 2000-05-05
CIK: 0001023024 0001023024
ISIN: US00182C1036 US00182C1036
CUSIP: 00182C103 00182C103
Beta: 0.71 0.71
Last Dividend: 0.00 0.00
Dcf Diff: 107.43 107.43
Dcf: -53.27 -53.27
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.